Biography

Dr. Ferrer is a researcher at the Josep Carreras Leukaemia Research Institute. He is also an adjunct researcher at the Feinstein Institutes for Medical Research in New York and an associate professor at the University of Vic.

His research integrates translational, computational, and functional approaches to investigate leukemia evolution, clonal hematopoiesis, and tumor–immune interactions in hematological malignancies. By combining advanced genomic technologies with clinically annotated patient cohorts, his work aims to identify novel biomarkers and therapeutic vulnerabilities that can improve disease stratification and guide precision medicine strategies. A particular focus of his research is the interplay between epigenetic regulation and immune responses, with the goal of developing innovative immunotherapy and personalized treatments for leukemia and related blood disorders.

CURRENT GRANTS

AJT-PRJ2100756 · Fundació "la Caixa"

Somatic mutations and clonal hematopoiesis as predictors and drivers of heart failure progression

AJT-PRJ2301104 · Deutsche José Carreras Leukämie Stiftung

Refinement of Epigenetic Factors to Improve CAR T Cell Therapeutic Efficacy

AJT-PRS2400601 · Instituto de Salud Carlos III

Contratos Miguel Servet 2024

AJT-PRJ2401313 · CLL Global Research Foundation

Gene Expression Regulation Study Mediated by the RNA-Binding Protein Musashi2 and the RNA Methyladenosine Transferase 3, as Therapeutic Targets in Chronic Lymphocytic Leukemia